CapMan Oyj Series B
CapMan Oyj is a leading Nordic private assets management and investment firm with an active approach to value creation and private equity and venture capital firm specializing in growth capital investments, industry consolidation, special situations, turnaround, recapitalization, middle market buyouts, credit and mezzanine financing in unquoted companies, investments in value-add and income focus… Read more
CapMan Oyj Series B (0E1L) - Total Liabilities
Latest total liabilities as of December 2025: €143.25 Million EUR
Based on the latest financial reports, CapMan Oyj Series B (0E1L) has total liabilities worth €143.25 Million EUR as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CapMan Oyj Series B - Total Liabilities Trend (2002–2025)
This chart illustrates how CapMan Oyj Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CapMan Oyj Series B Competitors by Total Liabilities
The table below lists competitors of CapMan Oyj Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Humacyte Inc
NASDAQ:HUMA
|
USA | $96.26 Million |
|
Global Indemnity Group, LLC Class A Common Stock
NASDAQ:GBLI
|
USA | $1.01 Trillion |
|
Linhai Co Ltd
SHG:600099
|
China | CN¥602.01 Million |
|
Dutch Lady Milk Industries Bhd
KLSE:3026
|
Malaysia | RM487.47 Million |
|
Halla Holdings Corp
KO:060980
|
Korea | ₩1.27 Trillion |
|
Panda Dairy Corp
SHE:300898
|
China | CN¥108.20 Million |
|
Caribou Biosciences Inc
NASDAQ:CRBU
|
USA | $57.46 Million |
Liability Composition Analysis (2002–2025)
This chart breaks down CapMan Oyj Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 93.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CapMan Oyj Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CapMan Oyj Series B (2002–2025)
The table below shows the annual total liabilities of CapMan Oyj Series B from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €143.25 Million | +1.77% |
| 2024-12-31 | €140.75 Million | +11.34% |
| 2023-12-31 | €126.42 Million | -1.52% |
| 2022-12-31 | €128.37 Million | +13.73% |
| 2021-12-31 | €112.87 Million | +6.98% |
| 2020-12-31 | €105.50 Million | +21.27% |
| 2019-12-31 | €87.00 Million | +2.31% |
| 2018-12-31 | €85.03 Million | +0.55% |
| 2017-12-31 | €84.56 Million | -22.92% |
| 2016-12-31 | €109.72 Million | +29.91% |
| 2015-12-31 | €84.45 Million | +74.71% |
| 2014-12-31 | €48.34 Million | +6.06% |
| 2013-12-31 | €45.58 Million | -8.20% |
| 2012-12-31 | €49.65 Million | -8.48% |
| 2011-12-31 | €54.25 Million | -16.28% |
| 2010-12-31 | €64.80 Million | +1.53% |
| 2009-12-31 | €63.83 Million | -7.30% |
| 2008-12-31 | €68.85 Million | +38.23% |
| 2007-12-31 | €49.81 Million | +120.27% |
| 2006-12-31 | €22.61 Million | +178.90% |
| 2005-12-31 | €8.11 Million | +52.04% |
| 2004-12-31 | €5.33 Million | +54.80% |
| 2003-12-31 | €3.44 Million | -24.18% |
| 2002-12-31 | €4.54 Million | -- |